Biotech Speaker Series

Join fellow alumni as panelists Sean Barrett, MBA'10, Dale Brown, MBA'95, and Greg Hamilton, MBA'01, share insights on the sector as part of our on-going Biotech Speaker Series.

Cost: $30/person in advance; $35/person at the door; includes food and beverage

Online registration is closed. Walk-ins welcome! Cash or check only.

Join fellow alumni, family and friends for the fourth Biotech Speaker Series event. Hear local UChicago alumni Sean Barrette, MBA'10, Dale Brown, MBA'95, and Greg Hamilton, MBA'01, discuss what's new in personalized medicine and financing for proteomics, immunotherapy and pharmacogenetic-focused companies, as well as the state of the art in international pharmacy benefit management.

We'll hear about AltheaDx's recent successful $30 million Series C financing round in Q4 2015, as well as L Squared Capital's private equity biotech investment in Caprion Proteomics for its family office investors, and how pharmacy benefits management is expanding from the U.S. into the Middle East with MedImpact Arabia.

Don't miss this opportunity to learn more and network.


Sean Barrett, MBA'10, Partner, L Square Capital Partners

Sean Barrette is a Partner at L Squared Capital Partners and was actively engaged in the formation of the firm. Sean has worked closely with the founding members of L Squared Capital Partners as Principal at Chicago Growth Partners. Prior to CGP, Sean was an Analyst and Associate at Credit Suisse based out of New York and Singapore. Sean began his career as an auditor at Ernst & Young. He received his MBA from the University of Chicago Booth School of Business and a BS in Accounting and Economics from Binghamton University. Sean is a Chartered Financial Analyst (CFA) and Certified Public Accountant (CPA – inactive). Current Board Seats: Advanced Pain Management; Caprion Biosciences; ScribeAmerica; Virtium. Prior Board Seats: Lanx

Dale Brown, MBA ’95, Director and General Manager, MedImpact Arabia

Mr. Brown led the formation of MedImpact Arabia in 2011, the premiere pharmacy benefit manager (PBM) and ePrescribing company in the Middle East. MedImpact Arabia collaborates with health insurance payers, providers and regulators to significantly improve pharmacy care while lowering drug and administrative costs. Since 2011, MedImpact Arabia has adjudicated more than 40 million pharmacy transactions across 1000 pharmacies for over 1.6 million members in United Arab Emirates, Bahrain and Qatar. Prior to his current role, Mr. Brown held senior management positions at Humana, Caremark, Merck-Medco, and Cardinal Health after earning his MBA in finance and marketing from the University of Chicago, and his BA from the University of Illinois. He is a member of the University of Chicago Middle East Alumni Club.


Greg Hamilton, MBA ’01, CEO, AltheaDx

Mr. Hamilton has over 20 years of management experience in molecular diagnostics, manufacturing and professional service industries. Prior to joining AltheaDx, Mr. Hamilton was Chief Operating Officer and Chief Financial Officer of Enigma Diagnostics, Inc. and Vice President of Finance and Operations at Hologic Inc. (Formerly Third Wave Technologies). He has been responsible for multiple PMA and 510(k) cleared products including a Human Papilloma Virus (HPV) High Risk Screening assay and the first ever cleared HPV 16/18 genotyping assay. Mr. Hamilton received his MBA from the University of Chicago and his Bachelor of Science from Purdue University.


Event Contact
Kristina Peterson, MBA'90
Staff Contact
Ritu Prasad, AB'14